|
|
|
|
Adding endovascular treatment to standard care resulted in substantial clinical benefits at low costs. The results were consistent throughout irrespective of whether data from ESCAPE, EXTEND-IA, MR. CLEAN, REVASCAT, or SWIFT PRIME were used in this model. |
|